Long-Term Outcome of Renal Transplantation in Light-Chain Deposition Disease

American Journal of Kidney Diseases

Volumn 43, Issue 1, 2004, Pages 147-153

  Leung, Nelson ^b   Lager, Donna J ^b   Gertz, Morie A ^b   Wilson, Kirk ^b   Kanakiriya, Sharan ^b   Fervenza, Fernando C ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Kidney transplantation; Light chain deposition disease (LCDD); Monoclonal gammopathy

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; ARTICLE; ATROPHY; BIOACCUMULATION; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEMATURIA; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOGLOBULIN PRODUCTION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE BASEMENT MEMBRANE; LIGHT CHAIN DEPOSITION DISEASE; MALE; MESANGIUM CELL; MONOCLONAL IMMUNOGLOBULINEMIA; MORTALITY; MULTIPLE MYELOMA; OUTCOMES RESEARCH; PROGNOSIS; PROTEIN DETERMINATION; PROTEINURIA; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT INDICATION;

EID: 0347359329     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2003.09.020     Document Type: Article

References (25)

1. Ganeval D, Noel LH, Preud'homme JL, Droz D, Grunfeld JP: Light-chain deposition disease: Its relation with AL-type amyloidosis. Kidney Int 26:1-9, 1984
2. Confalonieri R, Barbiano di Belgiojoso G, Banfi G, et al: Light chain nephropathy: Histological and clinical aspects in 15 cases. Nephrol Dial Transplant 3:150-156, 1988
3. Randall RE, Williamson WC Jr, Mullinax F, Tung MY, Still WJ: Manifestations of systemic light chain deposition. Am J Med 60:293-299, 1976
4. Lin J, Markowitz GS, Valeri AM, et al: Renal monoclonal immunoglobulin deposition disease: The disease spectrum. J Am Soc Nephrol 12:1482-1492, 2001
5. Strom EH, Fogazzi GB, Banfi G, Pozzi C, Mihatsch MJ: Light chain deposition disease of the kidney: Morphological aspects in 24 patients. Virchows Arch 425:271-280. 1994
6. Ivanyi B: Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 114:986-987, 1990
7. Comotti C, Mazzon M, Valli A, Rovati C, Vivaldi P: Light chain deposition nephropathy in multiple myeloma. Contrib Nephrol 105:133-138, 1993
8. Montseny JJ, Kleinknecht D, Meyrier A, et al: Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant 13:1438-1445, 1998
9. Gertz MA, Lacy MQ, Dispenzieri A: Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: A status report. Bone Marrow Transplant 25:465-470, 2000
10. Pozzi C, Fogazzi GB, Banfi G, et al: Renal disease and patient survival in light chain deposition disease. Clin Nephrol 43:281-287, 1995
11. Buxbaum JN, Chuba JV, Hellman GC, Solomon A, Gallo GR: Monoclonal immunoglobulin deposition disease: Light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 112:455-464. 1990
12. Heilman RL, Velosa JA, Holley KE, Offord KP, Kyle RA: Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease. Am J Kidney Dis 20:34-41, 1992
13. Kyle RA, Gertz MA: Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol 32:45-59, 1995
14. Bonar L, Cohen AS, Skinner MM: Characterization of the amyloid fibril as a cross-beta protein. Proc Soc Exp Biol Med 131:1373-1375, 1969
15. Dagher F, Sammett D, Abbi R, et al: Renal transplantation in multiple myeloma: Case report and review of the literature. Transplantation 62:1577-1580, 1996
16. Gerlag PG, Koene RA, Berden JH: Renal transplantation in light chain nephropathy: Case report and review of the literature. Clin Nephrol 25:101-104, 1986
17. David-Neto E, Ianhez LE, Chocair PR, et al: Renal transplantation in systemic light-chain deposition (SLCD): A 44 month follow-up without recurrence. Transplant Proc 21:2128-2129, 1989
18. Lin JJ, Miller F, Waltzer W, Kaskel FJ, Arbeit L: Recurrence of immunoglobulin A-kappa crystalline deposition disease after kidney transplantation. Am J Kidney Dis 25:75-78, 1995
19. Hariharan S, Johnson CP, Bresnahan BA, et al: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605-612, 2000
20. Jacquot C, Saint-Andre JP, Touchard G, et al: Association of systemic light-chain deposition disease and amyloidosis: A report of three patients with renal involvement. Clin Nephrol 24:93-98, 1985
21. Noel LH, Droz D, Ganeval D, Grunfeld JP: Renal granular monoclonal light chain deposits: Morphological aspects in 11 cases. Clin Nephrol 21:263-269, 1984
22. Short AK, O'Donoghue DJ, Riad HN, Short CD, Roberts IS: Recurrence of light chain nephropathy in a renal allograft: A case report and review of the literature. Am J Nephrol 21:237-240, 2001
23. Gertz MA, Lacy MQ, Gastineau DA, et al: Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL), Bone Marrow Transplant 26:963-969, 2000
24. Dember LM, Sanchorawala V, Seldin DC, et al: Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease. Ann Intern Med 134:746-753, 2001
25. Pozzi C, Locatelli F: Kidney and liver involvement in monoclonal light chain disorders. Semin Nephrol 22:319-330.2002